Novocellbio in Korea Confirms NOVO-NK’s Promising Antiviral Effects Against COVID-19

August 10, 2020August 10, 2020 THE COVID REMEDY trials

Currently, Novocellbio Co., Ltd. is preparing for phase 1 clinical trial for NK cell therapy drug NOVO-NK, a study that is an indication for lung cancer.

Source: Novocellbio in Korea Confirms NOVO-NK’s Promising Antiviral Effects Against COVID-19

← On International Day, UN chief spotlights indigenous peoples’ resilience in face of COVID-19 …
Omeros Corporation Reports Recovery and Survival of All Patients in Study Evaluating … →